Type 2 diabetes. Type 2 diabetes mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Type 2 Diabetes patients Taking oral hypoglycemic drugs Age 20-65 years Satisfaction to enter the plan HbA?C < %?
Exclusion criteria
Exclusion criteria: Having serious gastrointestinal diseases including active stomach ulcers and gastrointestinal bleeding History of diabetic ketoacidosis, non-ketone hyperosmolar diabetic coma, severe infection or surgery in the previous month Kidney failure, liver dysfunction, cancers, cysts or breast mass, metabolic diseases Having a psychological illness Consumption of alcohol, drugs or psychotropic substances Uncontrolled hypertension (blood pressure greater than or equal to 100/160 mm Hg) History of myocardial infarction Taking anticoagulants (warfarin and Plavix ...) Insulin therapy over the past three months Continued use of herbs or other herbal medicines Fasting blood sugar above 180 Pregnancy, breastfeeding Having allergies to any of the plants
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting blood sugar. Timepoint: The beginning of the study, 3 months later. Method of measurement: laboratory kit.;Blood cholesterol. Timepoint: The beginning of the study, 3 months later. Method of measurement: Laboratory kit (blood test).;Blood triglycerides. Timepoint: The beginning of the study, 3 months later. Method of measurement: Laboratory kit (blood test). | — |
Secondary
| Measure | Time frame |
|---|---|
| HbA?C. Timepoint: The beginning of the study, 3 months later. Method of measurement: Laboratory kit (blood test). | — |
Countries
Iran (Islamic Republic of)
Contacts
Tehran University of Medical Sciences